# Akebia Therapeutics, Inc.: Lenders, Customers and Owners

> US
>
> 4 links from the documents that the companies file and the register of legal entities, as of 2026-11-13. A commitment is the commitment at the date of the agreement.

Page: https://annalist.io/atlas/akebia-therapeutics-inc/

## Customers (4)

| Entity | Figure | Evidence | Documents |
| --- | --- | --- | --- |
| [DaVita, Inc.](https://annalist.io/atlas/davita-inc/brief.md) | 25% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | [1] |
| [Cencora, Inc.](https://annalist.io/atlas/cencora/brief.md) | 19% of the revenue of the supplier, fiscal year ended 31 Dec 2024 | Stated | [1] |
| [Mc Kesson Corporation](https://annalist.io/atlas/mc-kesson-corporation/brief.md) | 12% of the revenue of the supplier, fiscal year ended 31 Dec 2024 | Stated | [1] |
| [Cardinal Health, Inc.](https://annalist.io/atlas/cardinal-health/brief.md) | 10% of the revenue of the supplier, fiscal year ended 31 Dec 2023 | Stated | [1] |

## Source Documents

- [1] Form 10-K for the fiscal year ended 31 December 2025, 26 Feb 2026 (https://www.sec.gov/Archives/edgar/data/1517022/000151702226000020/0001517022-26-000020-index.htm)

## Full Data

- [Every link of this entity with its claims (JSON)](https://annalist.io/api/v1/atlas/akebia-therapeutics-inc.json)
- [The map of every entity (JSON)](https://annalist.io/api/v1/atlas.json)
- [Every link in one table (CSV)](https://annalist.io/api/v1/panel/links.csv.gz)

---

Figures come from official filings and are provided as they are, without warranty of accuracy or completeness. They are not investment advice.